IMRT for Glioblastoma: A Study on Survival Outcomes
Author Information
Author(s): Fuller Clifton D, Choi Mehee, Forthuber Britta, Wang Samuel J, Rajagiriyil Nancy, Salter Bill J, Fuss Martin
Primary Institution: The University of Texas Health Science Center at San Antonio
Hypothesis
Does intensity-modulated radiation therapy (IMRT) improve survival outcomes for glioblastoma multiforme (GBM) patients compared to historical controls?
Conclusion
IMRT did not improve survival outcomes for GBM patients compared to historical controls.
Supporting Evidence
- 42 patients were treated with IMRT, with a median survival of 8.7 months.
- 88% of patients were deceased at last contact.
- Nonparametric analysis showed no survival difference between IMRT-boost and IMRT-only groups.
Takeaway
Doctors tried a new way to treat brain tumors called IMRT, but it didn't help patients live longer than older treatments.
Methodology
Retrospective chart review of 42 patients treated with IMRT for GBM.
Potential Biases
Potential biases due to the retrospective nature of the study and variability in treatment regimens.
Limitations
The study is retrospective and has a limited sample size with heterogeneous treatment schemas.
Participant Demographics
{"age":{"median":60,"range":"20–86"},"sex":{"male":27,"female":15},"surgery":{"biopsy":8,"debulking":34},"chemotherapy":{"none":19,"any":23}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website